We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biopharma Credit Plc | LSE:BPCR | London | Ordinary Share | GB00BDGKMY29 | ORD USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.002 | -0.23% | 0.876 | 0.874 | 0.878 | 0.878 | 0.874 | 0.878 | 1,203,046 | 11:38:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 135.74M | 108.45M | 0.0833 | 10.56 | 1.15B |
TIDMBPCR
RNS Number : 3359C
BioPharma Credit PLC
12 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ----------------------------------------------- 1. Identity of the issuer or the underlying BioPharma Credit PLC issuer of existing shares to which voting rights are attached: ------------------------------------------------------------------------- -------------------------- 2. Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ----------------------------------------------------------------------------------------------- ---- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------------------------------------- ---- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ----------------------------------------------------------------------------------------------- ---- An event changing the breakdown of voting rights ----------------------------------------------------------------------------------------------- ---- Other (please Issue of New Shares Yes specify): ------------------------------------------------------------------------ --------------------- ---- 3. Full name of person(s) subject Phemus Corporation to the notification obligation: ------------------------------------------------------------------------- -------------------------- 4. Full name of shareholder(s) (if different from 3.): ------------------------------------------------------------------------- -------------------------- 5. Date of the transaction and date 27 March 2017 on which the threshold is crossed or reached: ------------------------------------------------------------------------- -------------------------- 6. Date on which issuer notified: 12 April 2017 ------------------------------------------------------------------------- -------------------------- 7. Threshold(s) that is/are crossed or reached: 4% ------------------------------------------------------------------------- -------------------------- 8. Notified details: ----------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ----------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- ---------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights Shares Voting Rights ------------- --------------- --------------- ------------- -------------------------- --------------------------- Direct/ Direct Indirect Direct Indirect Indirect ------------- ----------- ----------- ------------- ------------- ----------- ------------ ------------- ORD USD0.01 Below 5% Below 5% 32,688,075 32,688,075 4.3% --------------- --------------- ------------- ------------- ----------- ------------ ------------- GB00BDGKMY29 ------------- ----------- ----------- ----------- ----------- ----------- -------- ----------- B: Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period rights that may rights instrument be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------ ---------------------------- ----------------------- N/A N/A N/A N/A N/A ----------------- ------------- ------------------------------ ---------------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date Conversion rights instrument instrument period refers to --------------- ------------- ------------- --------------- ---------------------------- ------------------------- N/A N/A N/A N/A N/A Nominal Delta --------------- ------------- ------------- --------------- ---------------------------- ------------ ----------- N/A N/A ------------- ----------- ----------- ----------- ----------- ----------- ------------ ----------- Total (A+B+C) ----------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- -------------------------------------------------------------------- 32,688,075 4.3% ------------------------------------------------- -------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ---------------------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ---------------------------------------------------------------------------- ---------------- 11. Number of voting rights proxy holder will cease to hold: ---------------------------------------------------------------------------- ---------------- 12. Date on which proxy holder will cease to hold voting rights: ---------------------------------------------------------------------------- ---------------- 13. Additional information: ---------------------------------------------------------------------------- ---------------- 14. Contact name: Sean C.Rogers ---------------------------------------------------------------------------- ---------------- 15. Contact telephone number: +1-617-720-6561 ---------------------------------------------------------------------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUURRBRASAAR
(END) Dow Jones Newswires
April 12, 2017 06:24 ET (10:24 GMT)
1 Year Biopharma Credit Chart |
1 Month Biopharma Credit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions